Unknown

Dataset Information

0

Pharmacological activation of Sirt1 ameliorates polyglutamine-induced toxicity through the regulation of autophagy.


ABSTRACT: Intracellular accumulation of polyglutamine (polyQ)-expanded Huntingtin (Htt) protein is a hallmark of Huntington's disease (HD). This study evaluated whether activation of Sirt1 by the anti-cancer agent, ?-lapachone (?-lap), induces autophagy in human neuroblastoma SH-SY5Y cells, thereby reducing intracellular levels of polyQ aggregates and their concomitant cytotoxicity. Treatment of cells with ?-lap markedly diminished the cytotoxicity induced by forced expression of Htt exon 1 containing a pathogenic polyQ stretch fused to green fluorescent protein (HttEx1(97Q)-GFP). ?-lap increased autophagy in SH-SY5Y cells, as evidenced by the increased formation of LC3-II and autolysosomes. Furthermore, ?-lap reduced HttEx1(97Q)-GFP aggregation, which was significantly prevented by co-incubation with 3-methyladenine, an inhibitor of autophagy. ?-lap increased Sirt1 activity, as shown by the increased deacetylation of the Sirt1 substrates, PARP-1 and Atg5, and the nuclear translocation of FOXO1. Both the induction of autophagy and attenuation of HttEx1(97Q)-GFP aggregation by ?-lap were significantly prevented by co-incubation with sirtinol, a general sirtuin inhibitor or by co-transfection with shRNA against Sirt1. The pro-autophagic actions of ?-lap were further investigated in a transgenic Caenorhabditis elegans (C. elegans) line that expressed Q67 fused to cyanine fluorescent protein (Q67). Notably, ?-lap reduced the number of Q67 puncta and restored Q67-induced defects in motility, which were largely prevented by pre-treatment with RNAi against sir-2.1, the C. elegans orthologue of Sirt1. Collectively, these data suggest that ?-lap induces autophagy through activation of Sirt1, which in turn leads to a reduction in polyQ aggregation and cellular toxicity. Thus, ?-lap provides a novel therapeutic opportunity for the treatment of HD.

SUBMITTER: Shin BH 

PROVIDER: S-EPMC3677867 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pharmacological activation of Sirt1 ameliorates polyglutamine-induced toxicity through the regulation of autophagy.

Shin Bae Hyun BH   Lim Yunki Y   Oh Hye Jin HJ   Park Sang Min SM   Lee Sun-Kyung SK   Ahnn Joohong J   Kim Do Han DH   Song Woo Keun WK   Kwak Tae Hwan TH   Park Woo Jin WJ  

PloS one 20130610 6


Intracellular accumulation of polyglutamine (polyQ)-expanded Huntingtin (Htt) protein is a hallmark of Huntington's disease (HD). This study evaluated whether activation of Sirt1 by the anti-cancer agent, β-lapachone (β-lap), induces autophagy in human neuroblastoma SH-SY5Y cells, thereby reducing intracellular levels of polyQ aggregates and their concomitant cytotoxicity. Treatment of cells with β-lap markedly diminished the cytotoxicity induced by forced expression of Htt exon 1 containing a p  ...[more]

Similar Datasets

| S-EPMC10827549 | biostudies-literature
| S-EPMC5590795 | biostudies-literature
| S-EPMC7755709 | biostudies-literature
| S-EPMC4326573 | biostudies-literature
| S-EPMC4824569 | biostudies-literature
| S-EPMC7658242 | biostudies-literature
| S-EPMC3448832 | biostudies-literature
| S-EPMC8273810 | biostudies-literature
| S-EPMC7782552 | biostudies-literature
| S-EPMC5524634 | biostudies-literature